Century Therapeutics

On Day 2 of the Advanced Therapies Congress and Expo, Century CSO Luis Borges will discuss Genetically engineered iPSC-derived immune cells for cancer immunotherapy" at 11:00 a.m. ET. He will also join a 1:00 p.m. panel discussion, Precision medicine for immunotherapy and give a talk at 4:00 p.m., Genetically engineered iPSC-derived immune cells for cancer immunotherapy. https://bit.ly/2Zh95d6 #celltherapy

Century is proud to be part of Philadelphia’s biotech ecosystem, targeting cancer with engineered #iPSC derived #celltherapy products. Check out Philadelphia Magazine's feature on our region’s cell and gene therapy hub in its Top Doctors issue. https://bit.ly/3fDkJ8J

Century Therapeutics Announces Formation of Scientific Advisory Board https://bit.ly/35yPqax #celltherapy #iPSCs

Century is happy to welcome Joe Jimenez to its Board of Directors and Greg Russotti as its CTO. https://bwnews.pr/2tL9lVv #celltherapy #biotech

Century's Carl Burke contributed to a new #NAMPerspectives paper on risks to avoid on the path to #regulation for cell and gene therapy products. https://doi.org/10.31478/201909d #celltherapy

Our CEO Lalo Flores was honored to join Century's partner Fujifilm Cellular Dynamics International Friday to celebrate the opening of their 32,000-sq.ft. cell therapeutics facility in Madison. https://bit.ly/2lfyW4H